News

ADAG
Adagene Inc. News

This news view pulls recent coverage and headlines tied to ADAG.

Latest Close

$3.75

1y Change

$1.93 (+106.04%)

Market Cap

$247,772,224.00

Sector

Healthcare

Industry

Biotechnology

Recommendation

none

Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer

MarketBeat • May 19, 2026

Read article

Adagene to Participate in Two Upcoming Investor Conferences

GlobeNewswire • May 12, 2026

Read article

Adagene (ADAG) Partners With Incyte (INCY) to Evaluate Combination Therapy for Colorectal Cancer

Insider Monkey • Apr 20, 2026

Read article

Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

GlobeNewswire • Apr 17, 2026

Read article

Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

GlobeNewswire • Apr 14, 2026

Read article

Incyte (INCY) Is Up 6.2% After Positive Povorcitinib Data And New Oncology Collaboration - Has The Bull Case Changed?

Simply Wall St. • Apr 5, 2026

Read article